YOLFTbeta
Addex Therapeutics Ltd

Addex Therapeutics Ltd

ADXN · SW · Healthcare / Biotechnology

0.0322CHF-0.00 (-5.29%)

Price History

Full chart

Market Stats

Previous Close0.034
Open0.035
Day Range0.028 – 0.0358
52-Week Range0.018 – 0.0678
Volume4.41M
Market Cap4.67M
P/E (TTM)0.00
Forward P/E21.19
EPS-0.06
Dividend Yield0.00%
Beta1.96
50-Day Avg0.0309
200-Day Avg0.0429

About

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The company also develops ADX71149, which is in phase 1 for undisclosed indication; and GABAB PAM for the treatment pain, anxiety, addiction, chronic cough, and overactive bladder. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. for the develop mGlu2 PAM compounds for the treatment of human health; and license and research agreement with Indivior PLC discovery, development, and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is based in Geneva, Switzerland.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Timothy Mark Dyer
  • Employees3
  • HeadquartersChemin des Mines, 9, Geneva, Switzerland, 1202, Switzerland
  • Websitehttps://www.addextherapeutics.com

Leadership

  • Mr. Timothy Mark DyerCo-Founder, CEO & Director · b. 1968
  • Dr. Roger G. Mills M.D.Chief Medical Officer & Director · b. 1957
  • Mr. Lénaic TeyssédouHead of Finance · b. 1985
  • Dr. Mikhail Kalinichev Ph.D.Head of Translational Science · b. 1967

Financials

Income Statement

Currency: CHF2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.74M486.93K26.81M4.09M1.98M2.82M121.09K91.76K85.40K40.30K17.33K499.89K6.04M2.76M3.61M2.92M1.42M1.61M410.04K173.00K
Growth (%)--89.72%+5405.28%-84.74%-51.71%+42.94%-95.71%-24.22%-6.93%-52.81%-57.00%+2784.73%+1109.03%-54.29%+30.77%-19.28%-51.22%+13.39%-74.58%-57.81%
Cost of Revenue-----27.99M1.27M91.76K85.40K40.30K17.33K29.76K144.17K230.10K10.37M12.82M14.62M6.93M854.30K8.47K
Gross Profit4.74M486.93K26.81M4.09M1.98M-25.16M-1.15M-2.00M49.73K30.11K-407.59K470.13K5.90M2.53M-6.49M-9.67M-13.20M-5.32M-444.26K164.39K
Gross Margin100.00%100.00%100.00%100.00%100.00%-891.19%-948.14%-2179.60%58.22%74.71%-2352.05%94.05%97.61%91.67%-179.75%-331.42%-928.06%-329.72%-108.35%95.02%
Operating Expense25.64M38.11M51.68M47.15M35.57M5.81M25.86M12.46M1.85M3.90M2.72M3.71M7.32M17.37M5.75M5.84M7.32M-3.08M2.31M2.98M
Operating Income-20.90M-37.62M-24.87M-43.05M-33.60M-30.97M-27.01M-14.46M-1.80M-3.87M-3.13M-3.24M-1.42M-14.83M-12.24M-15.51M-20.52M-2.24M-2.76M-2.81M
Operating Margin-441.03%-7726.28%-92.78%-1052.47%-1700.93%-1097.02%-22306.25%-15756.97%-2103.69%-9597.64%-18059.88%-647.15%-23.57%-536.92%-338.88%-531.70%-1442.61%-139.06%-671.94%-1627.17%
EBITDA-17.99M-33.26M-20.04M-39.86M-30.56M-28.05M-24.51M-13.75M-1.66M-4.18M-3.12M-3.27M-1.51M-14.32M-12.41M-14.94M-20.43M-10.26M-4.65M-2.81M
EBITDA Margin-379.66%-6830.55%-74.77%-974.30%-1547.10%-993.33%-20238.89%-14989.40%-1949.23%-10367.81%-18025.40%-653.17%-24.94%-518.25%-343.51%-512.34%-1436.42%-635.85%-1132.98%-1627.17%
Net Income-20.54M-35.09M-22.07M-42.69M-33.65M-31.14M-27.02M-14.46M-1.77M-4.20M-3.15M-3.28M-1.64M-14.78M-12.86M-15.41M-20.80M-10.56M7.06M-6.73M
Net Income Margin-433.53%-7205.50%-82.32%-1043.62%-1703.33%-1102.95%-22313.20%-15760.49%-2078.19%-10432.03%-18174.08%-656.22%-27.21%-534.98%-355.92%-528.58%-1462.57%-654.47%1720.75%-3889.60%
R&D9.77M12.21M44.19M39.96M31.16M-4.76M2.22M258.06K761.22K819.33K841.31K2.37M12.45M10.37M12.84M14.67M983.53K594.85K671.65K
R&D as % of Total Revenue206.19%2507.35%164.85%976.86%1577.75%-3927.65%2419.50%302.16%1888.83%4728.09%168.30%39.19%450.77%287.12%440.30%1031.01%60.98%145.07%388.24%
Interest Expense30.45K8.54K501.88K0144.81K239.37K000152.21K6.92K45.35K220.17K128.52K69.50K63.01K48.90K21.61K3.55K16.00K
Interest Expense % of Total Revenue0.64%1.75%1.87%0.00%7.33%8.48%0.00%0.00%0.00%377.68%39.96%9.07%3.64%4.65%1.92%2.16%3.44%1.34%0.87%9.25%

Balance Sheet

Currency: CHF2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets46.35M149.37M132.33M88.55M74.28M43.62M21.74M5.88M4.00M2.89M1.68M3.06M42.21M33.03M20.18M22.54M8.28M4.64M10.67M6.36M
Total Liabilities4.07M9.27M13.34M10.97M9.87M9.78M5.44M2.85M1.65M1.23M1.46M1.72M2.97M7.50M5.57M5.61M3.37M3.50M1.00M1.60M
Total Equity42.28M140.11M118.99M77.58M64.41M33.84M16.29M3.03M2.35M1.66M218.59K1.34M39.24M25.52M14.61M16.93M4.91M1.15M9.67M4.76M
Cash40.95M140.04M119.47M76.56M63.80M36.07M15.26M2.91M1.98M2.63M1.42M2.59M41.67M31.54M18.70M20.48M6.96M3.87M3.34M1.64M
Total Debt126.57K------------550.25K567.40K482.02K373.13K344.34K41.99K34.69K
Net Debt-40.82M-140.04M-119.47M-76.56M-63.80M-36.07M-15.26M-2.91M-1.98M-2.63M-1.42M-2.59M-41.67M-30.99M-18.13M-20.00M-6.58M-3.52M-3.30M-1.60M

Cash Flow

Currency: CHF2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-19.56M-33.00M-17.79M-39.38M-31.34M-26.55M-29.45M-15.78M-1.80M-2.63M-2.69M-2.13M1.75M-9.48M-12.18M-14.71M-16.44M-7.99M-5.37M-2.17M
Investing Cash Flow-900.45K-193.49K-2.17M-3.90M-972.80K-758.27K-225.04K256.07K373.45K399.90K-1.51K-697-61.74K-43.25K-59.41K-30.31K2.97K-6.84K4.65M-680.69K
Financing Cash Flow39.61M132.31M-102.29K315.16K19.71M-183.25K8.90M3.18M472.65K2.93M1.49M3.36M37.39M-463.69K46.40K16.40M3.10M5.26M104.97K1.19M
Capital Expenditure357.41K2.73M5.61M4.21M453.02K204.31K330.91K011.22K11.22K11.22K6979.05K28.46K59.41K31.55K5816.84K1.27K0
Free Cash Flow-19.92M-35.73M-23.40M-43.59M-31.79M-26.75M-29.78M-15.78M-1.80M-2.63M-2.71M-2.14M1.74M-9.51M-12.24M-14.74M-16.44M-8.00M-5.37M-2.17M
Dividends Paid----------00000390.19K307.50K000
FCF to OCF101.83%108.27%131.53%110.69%101.45%100.77%101.12%100.00%100.00%100.00%100.42%100.03%99.48%100.30%100.49%100.21%100.00%100.09%100.02%100.00%
Dividend Paid to FCF----------0.00%0.00%0.00%0.00%0.00%-2.65%-1.87%0.00%0.00%0.00%

Earnings

Report DateJul 25, 2007May 2, 2016Sep 30, 2016May 16, 2017Sep 29, 2017May 4, 2018Jan 8, 2019Apr 30, 2019Sep 30, 2019Apr 8, 2020Aug 12, 2020Nov 3, 2020Mar 11, 2021May 5, 2021Aug 5, 2021Nov 3, 2021Mar 9, 2022May 5, 2022Jul 29, 2022Nov 11, 2022Mar 30, 2023May 11, 2023Aug 10, 2023Nov 29, 2023Dec 31, 2023Apr 18, 2024Sep 30, 2024Nov 21, 2024Dec 31, 2024May 15, 2025Sep 30, 2025Dec 4, 2025Mar 9, 2026Jun 16, 2026Sep 28, 2026Nov 9, 2026
EPS Estimate-1.600.000.000.000.000.000.000.000.00-0.16-0.12-0.12-0.08-0.10-0.12-0.13-0.10-0.15-0.13-0.09-0.21-0.04-0.04-0.03-0.03-0.03-0.01-0.01-0.01-0.010.00-0.00---
EPS Actual-3.30-0.13-0.11-0.18-0.14-0.110.10-0.15-0.29-0.27-0.12-0.12-0.08-0.08-0.14-0.11-0.13-0.15-0.19-0.09-0.21-0.04-0.04-0.03-0.03-0.03-0.01-0.02-0.01-0.01-0.02-0.020.00-0.02-0.01-
Surprise-106.25%---------68.75%0.00%0.00%0.00%20.00%-16.67%15.38%-30.00%0.00%-46.15%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-100.00%0.00%0.00%------
TimingPre-market------------Pre-marketPre-marketAfter-hoursAfter-hours-After-hoursPre-market--Pre-marketPre-market-Pre-marketPre-marketAfter-hours-After-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap4.67M
Enterprise Value2.78M
Trailing P/E0.00
Forward P/E21.19
PEG Ratio0.00
Price / Sales56.20
Price / Book1.10
EPS-0.06
Book Value0.011
Revenue (TTM)83.07K
Gross Profit (TTM)-272.18K
EBITDA-2.60M
Profit Margin0.00%
Operating Margin-6487.25%
Return on Equity-150.58%
Return on Assets-27.12%
Shares Outstanding210.29M
Shares Float141.93M
Beta1.96
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%